Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.

Talledo M, López G, Huyghe JR, Verdonck K, González E, Clark D, Senitzer D, Vanham G, Gotuzzo E, Van Camp G, Van Laer L.

Hum Immunol. 2010 Aug;71(8):804-8. doi: 10.1016/j.humimm.2010.05.011. Epub 2010 May 17.

PMID:
20483367
2.

Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1.

Talledo M, López G, Huyghe JR, Verdonck K, González E, Clark D, Vanham G, Gotuzzo E, Van Camp G, Van Laer L.

J Med Virol. 2012 Feb;84(2):319-26. doi: 10.1002/jmv.22255.

PMID:
22170554
3.

Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection.

Rafatpanah H, Pravica V, Faridhosseini R, Tabatabaei A, Ollier W, Poulton K, Thomson W, Hutchinson I.

Iran J Immunol. 2007 Jun;4(2):94-100.

4.

Evaluation of host genetic and viral factors as surrogate markers for HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian HTLV-1-infected patients.

Talledo M, López G, Huyghe JR, Verdonck K, Adaui V, González E, Best I, Clark D, Vanham G, Gotuzzo E, Van Camp G, Van Laer L.

J Med Virol. 2010 Mar;82(3):460-6. doi: 10.1002/jmv.21675.

PMID:
20087941
5.

Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals.

Sabouri AH, Saito M, Usuku K, Bajestan SN, Mahmoudi M, Forughipour M, Sabouri Z, Abbaspour Z, Goharjoo ME, Khayami E, Hasani A, Izumo S, Arimura K, Farid R, Osame M.

J Gen Virol. 2005 Mar;86(Pt 3):773-81.

PMID:
15722539
6.

Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis.

Vine AM, Witkover AD, Lloyd AL, Jeffery KJ, Siddiqui A, Marshall SE, Bunce M, Eiraku N, Izumo S, Usuku K, Osame M, Bangham CR.

J Infect Dis. 2002 Oct 1;186(7):932-9. Epub 2002 Sep 13.

PMID:
12232833
7.

Absence of consistent association between human leukocyte antigen-I and -II alleles and human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis risk in an HTLV-1 French Afro-Caribbean population.

Deschamps R, Béra O, Belrose G, Lezin A, Bellance R, Signate A, Cabre P, Smadja D, Césaire R, Olindo S.

Int J Infect Dis. 2010 Nov;14(11):e986-90. doi: 10.1016/j.ijid.2010.05.020. Epub 2010 Sep 17.

8.

Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.

Casseb J, de Oliveira AC, Vergara MP, Montanheiro P, Bonasser F, Meilman Ferreira C, Smid J, Duarte AJ.

J Med Virol. 2008 Mar;80(3):392-8. doi: 10.1002/jmv.21111.

PMID:
18205234
9.
10.

Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers.

Saito M, Braud VM, Goon P, Hanon E, Taylor GP, Saito A, Eiraku N, Tanaka Y, Usuku K, Weber JN, Osame M, Bangham CR.

Blood. 2003 Jul 15;102(2):577-84. Epub 2003 Jan 30.

PMID:
12560226
11.

ApaI polymorphism of vitamin D receptor gene is associated with susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in HTLV-1 infected individuals.

Saito M, Eiraku N, Usuku K, Nobuhara Y, Matsumoto W, Kodama D, Sabouri AH, Izumo S, Arimura K, Osame M.

J Neurol Sci. 2005 May 15;232(1-2):29-35.

PMID:
15850579
13.

Degenerate specificity of HTLV-1-specific CD8+ T cells during viral replication in patients with HTLV-1-associated myelopathy (HAM/TSP).

Kubota R, Furukawa Y, Izumo S, Usuku K, Osame M.

Blood. 2003 Apr 15;101(8):3074-81. Epub 2002 Dec 12.

PMID:
12480698
15.

Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis?

Lezin A, Olindo S, Oliere S, Varrin-Doyer M, Marlin R, Cabre P, Smadja D, Cesaire R.

J Infect Dis. 2005 Jun 1;191(11):1830-4. Epub 2005 Apr 28.

PMID:
15871115
16.

Polymorphisms at GLUT1 gene are not associated with the development of TSP/HAM in Brazilian HTLV-1 infected individuals and the discovery of a new polymorphism at GLUT1 gene.

Costa GC, Azevedo R, Gadelha SR, Kashima SH, Muricy G, Olavarria VN, Covas DT, Takayanagui OM, Galvão-Castro B, Alcantara LC.

J Med Virol. 2009 Mar;81(3):552-7. doi: 10.1002/jmv.21421.

PMID:
19152396
17.
19.

Impaired function of human T-lymphotropic virus type 1 (HTLV-1)-specific CD8+ T cells in HTLV-1-associated neurologic disease.

Sabouri AH, Usuku K, Hayashi D, Izumo S, Ohara Y, Osame M, Saito M.

Blood. 2008 Sep 15;112(6):2411-20. doi: 10.1182/blood-2008-02-140335. Epub 2008 May 23.

PMID:
18502825
20.

HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression.

Olindo S, Lézin A, Cabre P, Merle H, Saint-Vil M, Edimonana Kaptue M, Signate A, Césaire R, Smadja D.

J Neurol Sci. 2005 Oct 15;237(1-2):53-9.

PMID:
15972218

Supplemental Content

Support Center